GALMED PHARMACEUTICALS LTD. (EOCN) Total liabilities 2016–2020
GALMED PHARMACEUTICALS LTD. (EOCN) total liabilities at each fiscal year-end, per SEC filings.
$8.2MFY2020 · since FY2016: $5.4M → $8.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $8.2M | +12.9% |
| FY2019 | $7.3M | +169.3% |
| FY2018 | $2.7M | -29.7% |
| FY2017 | $3.8M | -28.4% |
| FY2016 | $5.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice